D. E. Shaw & Co., Inc. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 18 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$10,017,000
-55.9%
10,000,000
-55.3%
0.01%
-42.9%
Q1 2022$22,729,000
-18.5%
22,383,000
-15.2%
0.02%
-8.7%
Q4 2021$27,902,000
+1.6%
26,383,0000.0%0.02%
-8.0%
Q3 2021$27,474,000
+6.9%
26,383,000
+10.5%
0.02%
+13.6%
Q2 2021$25,711,000
-6.8%
23,883,0000.0%0.02%
-18.5%
Q1 2021$27,592,000
-10.1%
23,883,0000.0%0.03%0.0%
Q4 2020$30,704,000
+13.1%
23,883,0000.0%0.03%
-3.6%
Q3 2020$27,136,000
+73.7%
23,883,000
+77.7%
0.03%
+47.4%
Q2 2020$15,625,000
+138.6%
13,443,000
+126.2%
0.02%
+90.0%
Q1 2020$6,548,000
-32.7%
5,943,000
-29.6%
0.01%
-9.1%
Q4 2019$9,732,000
+11.0%
8,443,0000.0%0.01%0.0%
Q3 2019$8,768,000
-16.9%
8,443,000
-10.6%
0.01%
-15.4%
Q2 2019$10,552,000
+7.9%
9,443,0000.0%0.01%0.0%
Q1 2019$9,776,0009,443,0000.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 31,204,000$31,610,0000.98%
Opti Capital Management, LP 8,000,000$8,206,0000.66%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 14,527,000$15,076,0000.34%
TENOR CAPITAL MANAGEMENT Co., L.P. 15,519,000$15,848,0000.31%
CSS LLC/IL 7,007,000$7,112,0000.26%
WOLVERINE ASSET MANAGEMENT LLC 17,479,000$17,762,0000.17%
LMR Partners LLP 9,500,000$9,933,0000.12%
PALISADE CAPITAL MANAGEMENT, LP 4,672,000$4,858,0000.11%
Verition Fund Management LLC 8,091,000$8,233,0000.10%
Aequim Alternative Investments LP 2,000,000$2,035,0000.05%
View complete list of PTC THERAPEUTICS INC shareholders